The assessment of prognostic rules in patients with community-acquired pneumonia (CAP)

L. V. Koukol, S. A. Pupyshev, A. V. Pupyshev, B. I. Gelzer, V. A. Kudryavceva (Vladivostok, Russia)

Source: Annual Congress 2003 - Clinical aspects of community-acquired pneumonia
Session: Clinical aspects of community-acquired pneumonia
Session type: Thematic Poster Session
Number: 973
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. V. Koukol, S. A. Pupyshev, A. V. Pupyshev, B. I. Gelzer, V. A. Kudryavceva (Vladivostok, Russia). The assessment of prognostic rules in patients with community-acquired pneumonia (CAP). Eur Respir J 2003; 22: Suppl. 45, 973

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognostic factors of mortality in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2003; 22: Suppl. 45, 239s
Year: 2003

Biomarkers for the prognostic assessment and disease severity evaluation in community-acquired pneumonia (CAP)
Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Year: 2010


Diagnostic and prognostic utility of procalcitonin (PCT) measurements in patients with hospitalized community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009

Are there radiographic differences between patients with community-acquired (CAP) and healthcare-associated pneumonias (HCAP)?
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010


Physicians should not use the pneumonia severity index (PSI) or CRB-65 in deciding the need for hospitalization in cancer patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 41s
Year: 2007

Value of routine microbial investigation in low-risk patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2002; 20: Suppl. 38, 420s
Year: 2002

Another view on the prediction of outcomes in patients with community-acquired pneumonia
Source: Eur Respir J 2011; 38: 992-993
Year: 2011


Another view on the prediction of outcomes in patients with community-acquired pneumonia
Source: Eur Respir J 2011; 38: 991-992
Year: 2011


Applicability of Fine criteria in patients hospitalized for community-acquired pneumonia (CAP)
Source: Eur Respir J 2005; 26: Suppl. 49, 67s
Year: 2005

Decision making tool in the management of patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2004; 24: Suppl. 48, 538s
Year: 2004

Analysis of therapy of community-acquired pneumonia (CAP) at the COPD patients
Source: Annual Congress 2011 - COPD management
Year: 2011


Steroids are not associated with an improvement in clinical outcomes in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Year: 2009

Significant decrease in long-term survival for hospitalised patients with community-acquired pneumonia (CAP): results from the community-acquired pneumonia organisation (CAPO) international cohort study
Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia
Year: 2009


Community-acquired pneumonia in COPD patients: GOLD staging is a strong predicting factor of outcome of pneumonia
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010

Biomarkers and severity in community-acquired pneumonia (CAP)
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012


Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumonia
Source: Eur Respir J 2016; 48: 797-807
Year: 2016



Mortality directly related to community-acquired pneumonia (CAP) in hospitalized patients: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007


The presence of diabetes does not influence clinical outcomes in patients with community-acquired pneumonia: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia
Year: 2007


Is severity index enough to assess hospital admission of community-acquired pneumonia (CAP) patients?
Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia
Year: 2006


Validation of a predictive rule for the management of community-acquired pneumonia
Source: Eur Respir J 2006; 27: 151-157
Year: 2006